Results 201 to 210 of about 5,501,792 (312)
Implementation outcomes of video-observed oral fluid self-collection for drug testing in substance use disorder treatment: a pilot study. [PDF]
Bormann NL, Jannetto PJ, Oesterle TS.
europepmc +1 more source
Lactoferrin promotes wound healing by activating MAPK, PI3K/Akt, and extracellular matrix pathways, enhancing fibroblast remodeling, proliferation, and re‐epithelialization. These mechanisms highlight its therapeutic potential in inflammation control, tissue repair, and remodeling.
Morgana Lüdtke Azevedo +4 more
wiley +1 more source
Drug-related infectious diseases.
The EUDA collects data on the extent of infectious diseases — primarily HIV, hepatitis C and hepatitis B infection — among people who inject drugs (injecting drug users or IDUs).
core
A 3D Bioprinted Spheroid-Laden dECM-Enriched Osteosarcoma Model for Enhanced Drug Testing and Therapeutic Discovery. [PDF]
Domingues MF +6 more
europepmc +1 more source
NMR metabolomics revealed concentration‐dependent metabolic perturbations in HepG2 cells exposed to H2O2. Rifampicin pretreatment enhanced metabolic competence, attenuated toxin‐induced alterations and produced metabolite profiles more consistent with human liver physiology, supporting the use of CYP450‐induced HepG2 models for improved in vitro ...
Maren Jinks +4 more
wiley +1 more source
Biomimetic electrospun scaffolds for engineered heart tissue: from design parameters to drug testing platforms. [PDF]
Vaiciuleviciute R +7 more
europepmc +1 more source
Evaluating the effect of γ‐oryzanol on MASLD pathology using a medaka fish model
This study explores a liver disease called MASLD, which is increasing worldwide and can lead to serious damage. Researchers used medaka fish instead of rodents to test a food compound, γ‐oryzanol. Fish fed this compound had less liver fat and healthier gut bacteria.
Yukako Ito +7 more
wiley +1 more source
Dysregulated proteolytic cascades in Netherton syndrome: from molecular pathology to preclinical drug testing. [PDF]
Zingkou E +3 more
europepmc +1 more source
KDAC6 has been associated with cell motility and actin structures, but specific domain contributions are not established. The two catalytic domains have differential effects on motility and F‐actin regulation, affecting cortical F‐actin density, motility, stress fibers, and cell spreading.
Taylor V. Joseph +7 more
wiley +1 more source

